Immix Biopharma (NASDAQ:IMMX) Receives Buy Rating from HC Wainwright
Immix Biopharma (NASDAQ:IMMX – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $7.00 price objective on the stock. HC Wainwright’s price objective would indicate a potential upside of 219.63% from the stock’s […]
Immix Biopharma (NASDAQ:IMMX – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $7.00 price objective on the stock. HC Wainwright’s price objective would indicate a potential upside of 219.63% from the stock’s […]
